NextCure Inc reports results for the quarter ended in December - Earnings Summary

NextCure

03/03/2022 23:15

* NextCure Inc  NXTC.OQ  reported a quarterly adjusted loss
of 61
cents​​ per share for the quarter ended in December. The mean
expectation of eight analysts for the quarter was for a loss
of 67 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * NextCure Inc's reported EPS for the quarter was a loss
of 61
cents​.
    * The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * NextCure Inc shares had fallen by 19.5% this quarter.
    * The company reported a quarterly loss of $16.94 million.
    * Wall Street's median 12-month price target for NextCure
Inc is
$17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated March 3 at 11:15 p.m.  ​All
figures in US dollars unless otherwise stated